RecruitingNCT05783869
Study of Bronchiectasis and Associated Cardiovascular Comorbidities
Effect of Cardiovascular Comorbidities on Disease Severity and Quality of Life in Patients With Acute Exacerbation of Non-cystic Fibrosis Bronchiectasis
Sponsor
Assiut University
Enrollment
30 participants
Start Date
Mar 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Effect of cardiovascular comorbidities on disease severity and quality of life in Patients with acute exacerbation of non-cystic fibrosis bronchiectasis
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- Any Patients with Bronchiectasis had no comorbidities other than cardiovascular comorbidities during the study period.
Exclusion Criteria2
- Any Patients who refuse to participate in the study.
- Any other comorbidity or end-organ failure may affect the study's result.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEEchocardiography
echocardiographic study of both groups
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05783869
Related Trials
Bronchiectasis Phenotype Identification Model
NCT075999691 location
BASE: Bronchiectasis Severity and Exacerbation Risk Study
NCT075998391 location
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
NCT071927051 location
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892494 locations
Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases
NCT069833661 location